What's new

EMEA-000534-PIP03-17-M01

EMEA-000534-PIP03-17-M01

Jun 25, 2025 - 11:10
 0
EMEA-000534-PIP03-17-M01
EMEA-000534-PIP03-17-M01
Read More

Tags:

Previous Article

Opinion/decision on a Paediatric investigation plan (PIP): Steglatro, Ertugliflo...

Next Article

Q&A clinic on web-based electronic Application Form (eAF) functionalities for CA...

Related Posts

EMEA-003567-PIP01-23

EMEA-003567-PIP01-23

Jun 11, 2025  0

Human medicines European public assessment report (EPAR): Rybrevant, amivantamab, Date of authorisation: 09/12/2021, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 19, 2025  0

Summary of opinion: Saxenda, 22/05/2025 Positive

Summary of opinion: Saxenda, 22/05/2025 Positive

May 23, 2025  0